1. Home
  2. GLAS vs KMDA Comparison

GLAS vs KMDA Comparison

Compare GLAS & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

HOLD

Current Price

$4.08

Market Cap

504.2M

Sector

Health Care

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

SELL

Current Price

$7.84

Market Cap

460.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GLAS
KMDA
Founded
2015
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.2M
460.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
GLAS
KMDA
Price
$4.08
$7.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
★ $16.00
$13.50
AVG Volume (30 Days)
★ 1.4M
108.6K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
★ 5.20%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.49
$9.50
Revenue Next Year
$27.75
$12.63
P/E Ratio
★ N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$4.15
$6.55
52 Week High
$12.70
$9.35

Technical Indicators

Market Signals
Indicator
GLAS
KMDA
Relative Strength Index (RSI) 12.55 41.34
Support Level N/A $6.94
Resistance Level $10.53 $8.58
Average True Range (ATR) 0.52 0.20
MACD -0.18 -0.11
Stochastic Oscillator 4.23 13.06

Price Performance

Historical Comparison
GLAS
KMDA

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: